|
業務類別
|
-- |
|
業務概覽
|
Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales. |
| 公司地址
| 6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311 |
| 電話號碼
| +81 335254700 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.kyorin-pharm.co.jp |
| 員工數量
| 2297 |
| Mr. Yasuji Kurose |
Director, Chief Financial Officer, Chief Strategy Officer and General Manager, Corporate Planning Department |
-- |
19/06/2025 |
| Mr. Yutaka Ogihara |
Director, President and Chief Executive Officer |
-- |
19/06/2025 |
| Mr. Michiro Onota |
Director and Chief Marketing Officer |
-- |
19/06/2025 |
|
|
| Mr. Yasuji Kurose |
Director, Chief Financial Officer, Chief Strategy Officer and General Manager, Corporate Planning Department |
19/06/2025 |
| Mr. Yutaka Ogihara |
Director, President and Chief Executive Officer |
19/06/2025 |
| Mr. Michiro Onota |
Director and Chief Marketing Officer |
19/06/2025 |
| Mr. Noriyuki Shikanai |
Independent Director |
19/06/2025 |
| Mr. Ken Shigematsu |
Independent Director |
19/06/2025 |
| Ms. Hiromi Watanabe |
Independent Director |
19/06/2025 |
|
|
|
|
